110 related articles for article (PubMed ID: 8809172)
1. Rediscovering an endothelin antagonist (BQ-123): a self-deconvoluting cyclic pentapeptide library.
Spatola AF; Crozet Y
J Med Chem; 1996 Sep; 39(19):3842-6. PubMed ID: 8809172
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and conformational analysis of cyclic pentapeptide endothelin antagonists.
Lin M; Chan MF; Balaji VN; Castillo RS; Larive CK
Int J Pept Protein Res; 1996 Sep; 48(3):229-39. PubMed ID: 8897090
[TBL] [Abstract][Full Text] [Related]
3. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
Dutta AS; Crowther M; Gormley JJ; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Jamieson A; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Jul; 6(7):321-41. PubMed ID: 10946997
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
Vig BS; Murray TF; Aldrich JV
J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
[TBL] [Abstract][Full Text] [Related]
5. A conformational study by 1H NMR of a cyclic pentapeptide antagonist of endothelin.
Coles M; Sowemimo V; Scanlon D; Munro SL; Craik DJ
J Med Chem; 1993 Sep; 36(18):2658-65. PubMed ID: 8410978
[TBL] [Abstract][Full Text] [Related]
6. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
Dutta AS; Gormley JJ; Coath M; Hassall L; Hayward CF; Gellert PR; Kittlety RS; Alcock PJ; Ferguson R; Halterman T; Jamieson A; Moors JA; Moores JM; Rees A; Wood LJ; Reilly CF; Haworth D
J Pept Sci; 2000 Aug; 6(8):398-412. PubMed ID: 10969869
[TBL] [Abstract][Full Text] [Related]
7. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
Gardner A; Westfall TC; Macarthur H
J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
[TBL] [Abstract][Full Text] [Related]
8. Conformational study of cyclo[D-Trp-D-Asp-Pro-D-Val-Leu], an endothelin-A receptor-selective antagonist.
Atkinson RA; Pelton JT
FEBS Lett; 1992 Jan; 296(1):1-6. PubMed ID: 1309703
[TBL] [Abstract][Full Text] [Related]
9. Location of alkali metal binding sites in endothelin A selective receptor antagonists, cyclo(D-Trp-D-Asp-Pro-D-Val-Leu) and cyclo(D-Trp-D-Asp-Pro-D-Ile-Leu), from multistep collisionally activated decompositions.
Ngoka LC; Gross ML
J Mass Spectrom; 2000 Feb; 35(2):265-76. PubMed ID: 10679990
[TBL] [Abstract][Full Text] [Related]
10. BQ-153, a novel endothelin (ET)A antagonist, attenuates the renal vascular effects of endothelin-1.
Cirino M; Motz C; Maw J; Ford-Hutchinson AW; Yano M
J Pharm Pharmacol; 1992 Sep; 44(9):782-5. PubMed ID: 1360536
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of potent and selective alpha(4)beta(7) integrin antagonists.
Boer J; Gottschling D; Schuster A; Semmrich M; Holzmann B; Kessler H
J Med Chem; 2001 Aug; 44(16):2586-92. PubMed ID: 11472212
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1-evoked calcium transients in UMR-106 osteoblastic osteosarcoma cells are mediated through endothelin-A and endothelin-B receptors.
Semler DE; Ohlstein EH; Nambi P; Slater C; Stern PH
J Pharmacol Exp Ther; 1995 Mar; 272(3):1052-8. PubMed ID: 7891315
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.
Balse-Srinivasan P; Grieco P; Cai M; Trivedi D; Hruby VJ
J Med Chem; 2003 Aug; 46(17):3728-33. PubMed ID: 12904077
[TBL] [Abstract][Full Text] [Related]
14. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides.
Viles JH; Mitchell JB; Gough SL; Doyle PM; Harris CJ; Sadler PJ; Thornton JM
Eur J Biochem; 1996 Dec; 242(2):352-62. PubMed ID: 8973654
[TBL] [Abstract][Full Text] [Related]
15. Solution conformation of a cyclic pentapeptide endothelin antagonist. Comparison of structures obtained from constrained dynamics and conformational search.
Krystek SR; Bassolino DA; Bruccoleri RE; Hunt JT; Porubcan MA; Wandler CF; Andersen NH
FEBS Lett; 1992 Mar; 299(3):255-61. PubMed ID: 1544503
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of cyclic peptide-based chemokine receptor CXCR4 antagonists: disclosing the importance of side-chain and backbone functionalities.
Ueda S; Oishi S; Wang ZX; Araki T; Tamamura H; Cluzeau J; Ohno H; Kusano S; Nakashima H; Trent JO; Peiper SC; Fujii N
J Med Chem; 2007 Jan; 50(2):192-8. PubMed ID: 17228861
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-binding inhibitors, BE-18257A and BE-18257B II. Structure determination.
Nakajima S; Niiyama K; Ihara M; Kojiri K; Suda H
J Antibiot (Tokyo); 1991 Dec; 44(12):1348-56. PubMed ID: 1778787
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides.
Rivier JE; Kirby DA; Erchegyi J; Waser B; Eltschinger V; Cescato R; Reubi JC
J Med Chem; 2005 Jan; 48(2):515-22. PubMed ID: 15658865
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acids.
Tanaka T; Nomura W; Narumi T; Esaka A; Oishi S; Ohashi N; Itotani K; Evans BJ; Wang ZX; Peiper SC; Fujii N; Tamamura H
Org Biomol Chem; 2009 Sep; 7(18):3805-9. PubMed ID: 19707686
[TBL] [Abstract][Full Text] [Related]
20. Endothelin ETB receptors couple to two distinct signaling pathways in porcine kidney epithelial LLC-PK1 cells.
Ozaki S; Ihara M; Saeki T; Fukami T; Ishikawa K; Yano M
J Pharmacol Exp Ther; 1994 Sep; 270(3):1035-40. PubMed ID: 7932150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
